These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12361201)

  • 41. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
    Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
    Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study.
    Blanchet PJ; Fang J; Hyland K; Arnold LA; Mouradian MM; Chase TN
    Neurology; 1999 Jul; 53(1):91-5. PubMed ID: 10408542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB; Silfverstolpe G; Tengborn L
    Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of myocardial contractility by pulsed wave Doppler tissue imaging does not reveal an inotropic effect of estrogen at physiologic dose.
    Mercuro G; Zoncu S; Paoletti AM; Melis GB; Vacca AM; Cherchi A
    Am J Cardiol; 1999 Jun; 83(12):1677-9, A7. PubMed ID: 10392878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of estrogen therapy on insulin resistance and plasminogen activator inhibitor type 1 concentrations in postmenopausal women.
    Saucedo R; Basurto L; Zarate A; Martínez C; Hernandez M; Galván R
    Gynecol Obstet Invest; 2007; 64(2):61-4. PubMed ID: 17264514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
    Stevenson JC; Oladipo A; Manassiev N; Whitehead MI; Guilford S; Proudler AJ
    Br J Haematol; 2004 Mar; 124(6):802-8. PubMed ID: 15009069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study.
    Baker LD; Sambamurti K; Craft S; Cherrier M; Raskind MA; Stanczyk FZ; Plymate SR; Asthana S
    Am J Geriatr Psychiatry; 2003; 11(2):239-44. PubMed ID: 12611754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
    Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
    Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol.
    Ginsburg ES; Walsh BW; Gao X; Gleason RE; Feltmate C; Barbieri RL
    J Soc Gynecol Investig; 1995; 2(1):26-9. PubMed ID: 9420845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.
    Delmas PD; Pornel B; Felsenberg D; Garnero P; Hardy P; Pilate C; Dain MP
    Bone; 1999 May; 24(5):517-23. PubMed ID: 10321913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
    Duncan AC; Lyall H; Roberts RN; Petrie JR; Perera MJ; Monaghan S; Hart DM; Connell JM; Lumsden MA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute effects of transdermal estrogen on hemodynamic and vascular reactivity in elderly postmenopausal healthy women.
    Manhem K; Brandin L; Ghanoum B; Rosengren A; Gustafsson H
    J Hypertens; 2003 Feb; 21(2):387-94. PubMed ID: 12569270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.
    Zegura B; Keber I; Sebestjen M; Koenig W
    Atherosclerosis; 2003 May; 168(1):123-9. PubMed ID: 12732395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy.
    Saltevo J; Puolakka J; Ylikorkala O
    Diabetes Obes Metab; 2000 Oct; 2(5):293-8. PubMed ID: 11225744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.
    Vongpatanasin W; Tuncel M; Mansour Y; Arbique D; Victor RG
    Circulation; 2001 Jun; 103(24):2903-8. PubMed ID: 11413078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
    Karara AH; Hanes V; Alonso A; Ni P; Poola N; Silang R; Blode H; Preston RA
    J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.